BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 18084118)

  • 1. Short-term effects of pitavastatin on biochemical markers of bone turnover in patients with hypercholesterolemia.
    Majima T; Shimatsu A; Komatsu Y; Satoh N; Fukao A; Ninomiya K; Matsumura T; Nakao K
    Intern Med; 2007; 46(24):1967-73. PubMed ID: 18084118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term effects of atorvastatin on bone turnover in male patients with hypercholesterolemia.
    Majima T; Komatsu Y; Fukao A; Ninomiya K; Matsumura T; Nakao K
    Endocr J; 2007 Feb; 54(1):145-51. PubMed ID: 17185879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased bone turnover in patients with hypercholesterolemia.
    Majima T; Shimatsu A; Komatsu Y; Satoh N; Fukao A; Ninomiya K; Matsumura T; Nakao K
    Endocr J; 2008 Mar; 55(1):143-51. PubMed ID: 18219179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Increased Serum N-Terminal Telopeptide of Type I Collagen, a Biochemical Marker of Increased Bone Resorption, Is Associated with Infliximab Therapy in Patients with Crohn's Disease.
    Sugimoto K; Ikeya K; Iida T; Kawasaki S; Arai O; Umehara K; Watanabe F; Tani S; Oishi S; Osawa S; Yamamoto T; Hanai H
    Dig Dis Sci; 2016 Jan; 61(1):99-106. PubMed ID: 26254083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical utility of serum tartrate-resistant acid phosphatase 5b in the assessment of bone resorption in patients on peritoneal dialysis.
    Yamada S; Tsuruya K; Yoshida H; Taniguchi M; Haruyama N; Tanaka S; Eriguchi M; Nakano T; Kitazono T
    Clin Endocrinol (Oxf); 2013 Jun; 78(6):844-51. PubMed ID: 23078546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kidney transplantation restored uncoupled bone turnover in end-stage renal disease.
    Kawarazaki H; Shibagaki Y; Kido R; Nakajima I; Fuchinoue S; Ando K; Fujita T; Fukagawa M; Teraoka S; Fukumoto S
    Clin Nephrol; 2012 Jul; 78(1):10-6. PubMed ID: 22732332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary excretion of type I collagen cross-linked N-telopeptide and serum bone-specific alkaline phosphatase analysis to determine the correlation of age and back-pain related changes in elderly women.
    Kamimura M; Uchiyama S; Takahara K; Hashidate H; Kawaguchi A; Nakagawa H
    J Bone Miner Metab; 2005; 23(6):495-500. PubMed ID: 16261458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early changes in biochemical markers of bone formation predict BMD response to teriparatide in postmenopausal women with osteoporosis.
    Chen P; Satterwhite JH; Licata AA; Lewiecki EM; Sipos AA; Misurski DM; Wagman RB
    J Bone Miner Res; 2005 Jun; 20(6):962-70. PubMed ID: 15883636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct effects of physical training on markers of bone metabolism and serum sclerostin concentrations in older adults with low bone mass.
    Gombos GC; Bajsz V; Pék E; Schmidt B; Sió E; Molics B; Betlehem J
    BMC Musculoskelet Disord; 2016 Jun; 17():254. PubMed ID: 27278385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depletion and repletion of fruit and vegetable intake alters serum bone turnover markers: a 28-week single-arm experimental feeding intervention.
    Cao JJ; Whigham LD; Jahns L
    Br J Nutr; 2018 Sep; 120(5):500-507. PubMed ID: 30022739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High serum IGFBP-2 is predictive of increased bone turnover in aging men and women.
    Amin S; Riggs BL; Melton LJ; Achenbach SJ; Atkinson EJ; Khosla S
    J Bone Miner Res; 2007 Jun; 22(6):799-807. PubMed ID: 17352648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical usefulness of bone turnover markers with the treatment of osteoporosis].
    Miura M
    Clin Calcium; 2014 Mar; 24(3):367-76. PubMed ID: 24576933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum NTX is a practical marker for assessing antiresorptive therapy for glucocorticoid treated patients with chronic kidney disease.
    Hamano T; Fujii N; Nagasawa Y; Isaka Y; Moriyama T; Okada N; Imai E; Horio M; Ito T
    Bone; 2006 Nov; 39(5):1067-1072. PubMed ID: 16781904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of statins on biomarkers of bone metabolism: a randomised trial.
    Stein EA; Farnier M; Waldstreicher J; Mercuri M;
    Nutr Metab Cardiovasc Dis; 2001 Apr; 11(2):84-7. PubMed ID: 11434192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of dosing frequency of teriparatide (PTH 1-34) on bone formation in rats: comparison of bone metabolism marker levels.
    Watanabe A; Tsurui K; Yoneyama S; Iwata H; Anzai T; Jerome C; Nakae D
    J Toxicol Sci; 2018; 43(7):435-442. PubMed ID: 29973475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biochemical markers of age-related changes in bones turnover and bone mineral density in healthy Chinese men].
    Jiang YX; Tang SY; Wu XP; Yang LF; Liao EY
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Jan; 33(1):53-6. PubMed ID: 18245905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of bed rest during pregnancy on bone turnover markers in pregnant and postpartum women.
    Kaji T; Yasui T; Suto M; Mitani R; Morine M; Uemura H; Maeda K; Irahara M
    Bone; 2007 Apr; 40(4):1088-94. PubMed ID: 17229597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First-line therapy with thalidomide, dexamethasone and zoledronic acid decreases bone resorption markers in patients with multiple myeloma.
    Tosi P; Zamagni E; Cellini C; Parente R; Cangini D; Tacchetti P; Perrone G; Ceccolini M; Boni P; Tura S; Baccarani M; Cavo M
    Eur J Haematol; 2006 May; 76(5):399-404. PubMed ID: 16480429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum N-telopeptide of type I collagen and bone alkaline phosphatase and their relationship in patients with non-small cell lung carcinoma and bone metastases. Preliminary results.
    Lumachi F; Marino F; Fanti G; Chiara GB; Basso SM
    Anticancer Res; 2011 Nov; 31(11):3879-81. PubMed ID: 22110213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of risedronate in Japanese male patients with primary osteoporosis.
    Majima T; Shimatsu A; Komatsu Y; Satoh N; Fukao A; Ninomiya K; Matsumura T; Nakao K
    Intern Med; 2008; 47(8):717-23. PubMed ID: 18421187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.